Navigation Links
Roche Diabetes Care Forms Human Blue Circle, Supports Viral Video for World Diabetes Day
Date:11/11/2010

INDIANAPOLIS, Nov. 11, 2010 /PRNewswire/ -- Roche Diabetes Care, makers of ACCU-CHEK® products and services, is showing its support for World Diabetes Day (Nov. 14) through two truly collaborative initiatives.

(Photo: http://photos.prnewswire.com/prnh/20101111/DE99363)

(Photo: http://www.newscom.com/cgi-bin/prnh/20101111/DE99363)

Roche Diabetes Care formed its first human blue circle this year as a demonstration of support for people around the world with diabetes. The blue circle is the official logo of World Diabetes Day and is often duplicated in "human form" as a demonstrable act of support for WDD's effort to increase diabetes advocacy and awareness. Nearly 200 Roche employees formed the blue circle, which can be viewed on the ACCU-CHEK World Diabetes Day page.*

Roche Diabetes Care is also proud to have partnered with the Diabetes Hands Foundation, Diabetes Daily and Diabetes Stories to sponsor a video for the Big Blue Test. The video, located at http://www.youtube.com/watch?v=nkLHgK94Z0E, encourages people with diabetes to test their blood sugar on Nov. 14, get active for 14 minutes and then test again. The Big Blue Test, now in its second year, helps people with diabetes better understand the positive impact they can have on their blood sugar. Roche Diabetes Care underwrote the cost of the video's production and will make a donation for every view the video receives up to $75,000.

"The two initiatives underscore Roche's commitment to advocacy, awareness and education when it comes to diabetes," said Luc Vierstraete, senior vice president and general manager, Roche Diabetes Care North America. "We're thankful to have such wonderful partners in the diabetes community and hope that our Human Blue Circle and Big Blue Test video encourage others to get involved and make a difference in their communities."

World Diabetes Day is celebrated every year on Nov. 14 and was created by the International Diabetes Foundation and the World Health Organization. Since 2007 it has been recognized as an official United Nations Day.

* Publications may use the high-quality image attached to this release or e-mail todd.siesky@roche.com for an publish-ready image.

About Roche Diabetes CareRoche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients' condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management—from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems. For more information, please visit accu-chek.com.

About RocheHeadquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80,000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com or www.roche-diagnostics.us.

All trademarks used or mentioned in this release are protected by law.For further information, please contact: Todd Siesky Public Relations ManagerRoche Diabetes CareIndianapolis, IN(317) 521-3966 O(317) 361-7637 Ctodd.siesky@roche.com
'/>"/>

SOURCE Roche Diabetes Care
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
2. InterMune Sells Danoprevir Rights to Roche for $175 Million
3. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
4. Sanford Rose Associates(R)-Rochester Named Top Office
5. Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
6. Roche Diabetes Care and ICW Announce Technology Partnership
7. International Society for Cellular Therapy (ISCT) joins forces with Roche and Genzyme to launch Cell Therapy Industry Partnership.
8. X-Chem and Roche Enter Into Drug Discovery Collaboration and License Agreement
9. QIAGEN and Roche Settle Dispute Over Distribution Agreement for TheraScreen Companion Diagnostics
10. Cellular Dynamics and Roche Conduct Stem Cells in Drug Discovery and Development Workshop at the Society of Toxicology Annual Meeting
11. EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for ... time. So which eye do you rinse first if a dangerous substance enters both eyes? ... Eye Wash with its unique dual eye piece. , “Whether its dirt and debris, ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... compared the implantation and pregnancy rates in frozen and fresh in vitro ... of progesterone and maternal age to IVF success. , After comparing the results ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
Breaking Biology News(10 mins):